Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Matern Child Health J. 2017 Dec;21(12):2245–2255. doi: 10.1007/s10995-017-2346-4

Low-level Prenatal Toxin Exposures and Breastfeeding Duration: a Prospective Cohort Study

Casey B Rosen-Carole 1, Peggy Auinger 2, Cynthia R Howard 3, Elizabeth A Brownell 4, Bruce P Lanphear 5
PMCID: PMC5671900  NIHMSID: NIHMS894932  PMID: 28735496

Abstract

Introduction

Maternal exposure to tobacco smoke is associated with shortened breastfeeding duration, but few studies have examined the effects on breastfeeding outcomes of low level exposures to other toxic chemicals. Moreover, it is unclear if passive smoking is associated with duration of breastfeeding. Our objective was therefore to examine the effect of low-level prenatal exposures to common environmental toxins (tobacco smoke, lead, and phthalates) on breastfeeding exclusivity and duration.

Methods

We conducted an analysis of data from the HOME (Health Outcomes and Measures of the Environment) Study. Serum and urine samples were collected at approximately 16 and 26 weeks gestation and at delivery from 373 women; 302 breastfed their infants. Maternal infant feeding interviews were conducted a maximum of 8 times through 30 months postpartum. The main predictor variables for this study were gestational exposures to tobacco smoke (measured by serum cotinine), lead, and phthalates. Passive smoke exposure was defined as cotinine levels of 0.015–3.0 μg/mL. Primary outcomes were duration of any and exclusive breastfeeding.

Results

Serum cotinine concentrations were negatively associated with the duration of any breastfeeding (29.9 weeks unexposed vs. 24.9 weeks with passive exposure, p=0.04; and 22.4 weeks with active exposure, p=0.12; p=0.03 for linear trend), but not duration of exclusive breastfeeding. Prenatal levels of blood lead and urinary phthalate metabolites were not significantly associated with duration of any or exclusive breastfeeding.

Conclusions

Passive exposure to tobacco smoke during pregnancy was associated with shortened duration of any breastfeeding.

Keywords: breastfeeding, duration, prenatal, exposures, secondhand smoke, environmental tobacco smoke, cotinine, phthalates, lead

Introduction

Environmental contaminants, such as tobacco smoke, lead and phthalates, are transferred from mothers to infants transplacentally and via breast milk (Green and Marsit 2015; Dzwilewski and Schantz 2015; Shah-Kulkarni et al. 2016; LaKind et al. 2008; Kim et al. 2014). Research on the impact of environmental toxins on breastfeeding has focused on breast milk as a vehicle of infant exposure. (LaKind et al. 2004; LaKind et al. 2008; LaKind et al. 2015; Kim et al. 2015). Few studies have examined the effects on breastfeeding outcomes of low-level exposures to toxins during pregnancy. The Health Outcomes and Measures of the Environment (HOME) Study is a prospective cohort study of pregnant women and their infants to examine the impact of common environmental toxins on children’s health (Werner et al. 2015). Data were collected on breastfeeding, and toxins were evaluated for associations with breastfeeding outcomes. One recent report from this cohort found a shortened duration of breastfeeding at higher levels of serum perfluoroalkyl concentrations in pregnancy (Romano et al. 2016), raising the concern that other environmental contaminants may have a similar impact. Therefore, we sought to determine whether an association exists between breastfeeding outcomes and prenatal exposures to tobacco smoke, lead and phthalates, as they represent some of the most common household toxins (Jurewicz et al. 2013).

Breastfeeding initiation and duration appear to be negatively affected by both active and passive maternal smoking (Chou et al. 2008; Donath and Amir 2004; Kehler et al. 2009; Liu et al. 2006; Weiser et al. 2009; Amir and Donath 2002). Some studies have shown a dose-response relationship (Amir and Donath 2002), and stopping smoking in pregnancy may improve duration (Liu et al. 2006). The impact of prenatal passive exposure to tobacco smoke has been less widely studied, but has been associated with shortened breastfeeding duration. In the Krakow inner city prospective cohort study, 441 healthy 18–35 year old non-smoking women had blood cotinine levels measured at delivery. Women in high-exposure groups had higher risk of early cessation of any and exclusive breastfeeding (Jedrychowski et al. 2008a). Another group of 6747 Chinese infants were recruited in 1997–8 and followed for 9 months (Leung et al. 2002). Passive exposure to tobacco smoke in utero and postpartum were related to lower breastfeeding initiation but not duration in this sample. The impact of prenatal passive exposure on breastfeeding duration may be mediated by hormonal disruption or by toxic impacts on the developing mammary gland, which undergoes rapid hyperplasia and differentiation in pregnancy. Cotinine, a metabolite of nicotine, can be used as a reliable biomarker of tobacco smoke exposure and can be measured in the urine or serum (Jedrychowski et al. 2008a; CDC 2008).

Though there are studies on the transfer of lead to children via breastmilk, there are no studies of its effect on breastfeeding duration. Lead is well-known heavy metal toxin that has many sources, though it is predominantly found in areas highly exposed to lead-based paint and gasoline. Its effects on neurodevelopment are well-described, and are attributed to the interruption of varied cellular processes and therefore on neurological cellular organization (Garza et al. 2006). As lead freely passes the placenta, it is not surprising that that low-level prenatal exposures to lead may also affect children’s neurodevelopment (Shah-Kulkarni et al. 2016). Other heavy metals and metalloids, such as arsenic, mercury and cadmium, have been implicated as endocrine disruptors, though lead is not described in this way and the Endocrine Society calls for more research in this area. (Gore et al. 2015). It is therefore conceivable that lead could also play a role in endocrine pathways, thereby affecting breastfeeding and breastfeeding outcomes. Its effect on breastfeeding outcomes is therefore of interest because of its known toxic effects and high prevalence in the environment.

Phthalates are endocrine disruptors widely used in consumer and personal care products, and can enter the body by inhalation, ingestion, or skin absorption (Johns et al. 2015a Boas et al. 2012; Ye et al. 2014; Johns et al. 2015b). Higher exposures to phthalates have been associated with decreased anogenital distance (Braun et al. 2013), diminished oocyte yield for in-vitro fertilization (Hauser 2015), decreased maternal thyroid levels (Boas et al. 2012) and increased prenatal blood pressure and pregnancy-induced hypertensive diseases (Werner et al. 2015). Phthalates are metabolized and excreted in the urine. They have a short half-life, therefore urinary metabolites can be used as reasonable estimates of exposure in the past days or weeks (Braun et al. 2013).

Given the high prevalence of maternal exposure to tobacco smoke, lead, and phthalates, the biological plausibility of their impact on breastfeeding, and the lack of evidence about their effects on breastfeeding outcomes, this study aimed to test the effect of low-level prenatal exposures to these toxins on breastfeeding duration and exclusivity. A prospective birth cohort design was used to minimize reverse causality and thus strengthen the possibility that associations found may be causal.

Methods

Study sample

We conducted an analysis of data from the HOME Study, a prospective cohort study of pregnant women and their infants who were enrolled in Cincinnati, OH from 2003 to 2006 to examine the impact of common environmental toxins on children’s health (Werner et al. 2015). Pregnant women were enrolled from 9 prenatal clinics associated with 3 hospitals. Inclusion criteria included maternal age over 18 years old, pregnancy gestational age of 16 +/− 3 weeks, and living in a home built in 1978 or before (due to the widespread use of lead-based paint in houses built in this time period). Women were excluded if they had HIV or were taking medicines for seizure or thyroid disorders, all known to affect infant neurodevelopment. The study was approved by the Institutional Review Board of the Cincinnati Children’s Hospital Medical Center, participating hospitals and the Centers for Disease Control and Prevention (CDC).

Measurement of exposure

The main predictor variables for this study were gestational exposures to tobacco smoke (active or passive), lead, and phthalates. Maternal whole blood, serum and urine samples were collected at about 16 (range: 10–23) and 26 (range: 19–35) weeks gestation and at delivery, with less than 1% of the 16 week samples collected after 20 weeks gestation (Werner et al. 2015). Samples were stored at or below −20°C until analysis and measured at the CDC Division of Laboratory Sciences using previously described methods (Werner et al. 2015). Figure 1 shows a study flow diagram of the collection timeline of samples and surveys. Mean values of toxin exposures over the three time points were analyzed to ensure stability of exposure over time. “Gestational exposure” was defined as the mean level of exposure at 16 and 26 weeks gestation, and at delivery.

Figure 1.

Figure 1

Study Flow Diagram: timing of collection of samples and survey data

Serum Cotinine

Cotinine was used as a biomarker of tobacco smoke exposure because of its long half-life (15–20 hours) and high serum concentrations (10-fold higher than nicotine) (Lambers and Clark 1996). Serum samples were analyzed for cotinine using high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The limit of detection for this assay was 0.015μg/mL with a coefficient of variation ranging from 0.1–1μg/mL (Braun et al. 2010). Passive tobacco smoke exposure was defined as cotinine levels of 0.015–3.0 μg/mL; active tobacco exposure (active smokers) was defined as serum cotinine concentrations >3.0 μg/mL. (Jedrychowski et al. 2008a; CDC 2008)

Whole Blood Lead

Whole blood samples were measured for lead by inductively coupled plasma mass spectrometry (Nixon et al. 1999) with a limit of detection of 0.3 μg/dL. (Nixon et al. 1999; Jones et al. 2009) Though blood lead is not a good biomarker for long-term exposures, this was mitigated by the serial measurements during gestation (Barbosa et al. 2005).

Urinary Phthalate Metabolites

We measured 9 phthalate metabolites in urine (μg/L), including mono(2-ethyl-5-carboxypentyl phthalate (MECPP), mono-(2-ethylhexyl) phthalate (MEHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP), monobenzyl phthalate (MBzP), mono-3-carboxypropyl phthalate (MCPP), monoethyl phthalate (MEP), mono-butyl phthalate (MBP), and monoisobutyl phthalate (MiBP), using online solid phase extraction coupled to high performance liquid chromatography-isotope dilution tandem mass spectrometry (SPE HPLC-MS/MS) (Silva et al. 2007).

Measurement of outcome

The primary outcomes for this analysis were duration of any and exclusive breastfeeding. As measures of breastfeeding initiation reflect the choice to breastfeed, rather than function of the mammary gland, we focused instead on duration, which is a closer behavioral measure of milk supply. We surveyed mothers about breastfeeding 8 times, beginning at 4 weeks postpartum and continuing until children were 30 months of age (4 weeks and 3, 6, 9, 12, 18, 24 and 30 months). Duration of any breastfeeding was determined by response to the question “What was the total length of time (in weeks) since birth that {child participant} was fed at least some breast milk?” We asked this question after the mother reported having stopped feeding breast milk during an infant feeding interview. We treated the provision of mother’s milk by expression or direct breastfeeding equally. Exclusive breastfeeding duration was defined as the number of weeks before the start of any water, juice, formula, or food. We also asked mothers about breastfeeding behaviors, including previous breastfeeding experience, current breastfeeding duration, and whether they met their breastfeeding goals. Mothers of preterm and low birth weight infants were included.

Statistical analysis

We considered various potential confounders for inclusion in our statistical models, including the socio-demographic variables of maternal race, age at delivery, mode of delivery, previous live births, previous breastfeeding experience, whether breastfeeding goals had been attained, smokers in household, income, employment, plans to return to work, marital status, biological father/grandmother in the home and parental education. Neonatal Intensive Care Unit (NICU) stay, gestational age and intra-uterine growth were also measured. Covariates were collected during the baseline prenatal survey, based on factors known to be associated with breastfeeding (Sriraman and Kellams 2016; Dagher et al 2016; McLeod et al 2002; Cernadas et al. 2003). Chi square tests were used to determine statistically significant associations between these characteristics and rates of any breastfeeding. We used linear regression analyses to identify predictors of any and exclusive breastfeeding duration. Those who reported never feeding their infant breast milk were excluded from the regression analyses. We selected covariates on the basis of their association with breastfeeding in previous studies and included maternal race (white vs non-white), household income (under $25,000, $25,000–$50,000, $50,000–$80,000, and over $80,000), maternal plans to return to work after delivery, previous live births and breastfeeding experience (none, > 1 birth with previous breastfeeding, >1 birth without previous breastfeeding), biological father in the home, maternal education (≤ high school, some college, college degree and above), delivery type (vaginal vs cesarean), breastfed for as long as intended, and maternal age at delivery. These variables were tested for each outcome in stepwise linear regression models, with a significance level at entry of 0.10 and a significance level to remain in the model of 0.10.

We grouped cotinine results by exposure level as described above (passive exposure 0.015–3.0 μg/mL; active exposure >3.0 μg/mL). (Jedrychowski et al. 2008a; CDC 2008). Associations of cotinine with duration of any breastfeeding were modeled with adjustment for race and attainment of breastfeeding goals, while associations with exclusive breastfeeding duration were adjusted for race, breastfeeding goal, biological father in the home, and mode of delivery. We grouped blood lead concentrations and urinary phthalate concentrations by terciles to account for skewness of the distributions, and verified by log-transformation. Associations of lead with any breastfeeding duration were adjusted for race, attainment of breastfeeding goals, and maternal age, while associations with exclusive breastfeeding duration were adjusted for race, breastfeeding goals, biological father in the home and mode of delivery. For the models with urinary phthalates, we also included non-transformed creatinine concentrations in the models to account for urine dilution (Barr et al. 2005). Associations of phthalates with breastfeeding duration were adjusted for race, attained breastfeeding goals, maternal age and prenatal creatinine. Associations of phthalates with exclusive breastfeeding duration were adjusted for race, attained breastfeeding goals, biological father in the home, mode of delivery and prenatal creatinine.

Because the effect of toxins on breastfeeding may be mediated by impacts on mammary gland development, these analyses were also completed for a primiparous subgroup. Correlation analyses confirmed lack of collinearity among variables included in the regression models. To further understand the effects of exposure levels on breastfeeding outcomes, we report on the correlation with both adjusted p-values and linear trend analysis p-values. Analyses were performed using SAS version 9.3.

Results

Demographics and Breastfeeding Rates

Of the 468 women enrolled, 373 delivered live singleton babies and had complete outcome data (Table 1). Among this group of 373, 302 (81%) initiated breastfeeding, 190 (51%) were breastfeeding at 3 months, 138 (37%) were breastfeeding at 6 months. Exclusive breastfeeding rates were lower: 41 (11%) of women were exclusively breastfeeding at 3 months and 11 (0.3%) at 6 months. The average age of women who breastfed was 29.5 (SD 5.8).. About a quarter (25.7%) of households had an income below $25,000 per year, while another quarter (27.4%) had an income above $80,000 per year. A high percentage of women (76.7%) had more than a high school diploma, were employed during pregnancy (81.2%), and had plans to return to work after delivery (61.7%). The biologic father was present in 76.6% of households and 65.7% were married. About half of the sample (46.9%) was primiparous, and more than half (56%) had no prior breastfeeding experience.

Table 1.

Socio-demographic and biologic descriptors with relationship to breastfeeding initiation

Sample size % Overall % BF p-value for breastfeeding
All Mothers 373 100 81

Maternal Race 0.001
 White 239 64.1 86.2
 Non-white 134 35.9 71.6
Maternal age at delivery, y 373 29.5 (5.8)a

Mode of delivery 0.77
 Vaginal 268 71.9 81.3
 Cesarean 105 28.1 80

Infant gestational age
 by LMP 362 39.0 (1.8)a
 by ultrasound 33 37.8 (3.9)a
 by Ballard 292 38.7 (1.9)a

Infant birth weight, g 373 3382.5 (620.8)a

Intra-uterine growth 0.58
 AGA 283 75.9 79.9
 SGA 5 1.3 80
 LGA 80 21.5 85
 Unknown 5 1.3 --

Length of stay, d (NICU admission) 17 8.8 (8.7) a

Previous live births <0.001
 None 175 46.9 88
 1 114 30.6 81.6
 >1 83 22.2 65.1
 Unknown 1 0.3 --

Previous maternal breastfeeding 0.001
 Yes 157 42.1 89.8
 No 209 56 75.6
 Unknown 7 1.9 --

Breastfed for as long as intended --
 Yes 158 42.4 100
 No 118 31.6 100
 Did not breastfeed or unknown 97 26 --

Mother smokes 0.01
 Yes 46 12.3 67.4
 No 327 87.7 82.9

No. smokers in household 0.01
 None 280 75 84.3
 1 63 16.9 71.4
 >1 29 7.8 69
 Unknown 1 0.3 --

Household income <0.001
Under $25,000 96 25.7 62.5
Between $25,000 and $50,000 78 20.9 82.1
Between $50,000 and $80,000 90 24.1 87.8
Over $80,000 102 27.4 91.2
 Unknown 7 1.9 --

Maternal employment during pregnancy <0.001
 Yes 303 81.2 84.5
 No 70 18.8 65.7

Maternal plans to return to work after delivery 0.001
 Yes 230 61.7 86.1
 No 132 35.4 71.2
 Unknown 11 2.9 --

Maternal marital status <0.001
 Married 245 65.7 89.8
 Not married, but living with someone 50 13.4 70
 Not married, living alone 78 20.9 60.3

Biological father in home <0.001
 Yes 286 76.7 87.4
 No 87 23.2 59.8

Grandmother in home 0.32
 Yes 31 8.3 74.2
 No 342 91.7 81.6

Number of extended family members in home 0.001
 None 134 35.9 90.3
 1 120 32.2 81.7
 2 65 17.4 67.7
 >2 54 14.5 72.2

Maternal education <0.001
 < High school graduate 38 10.2 47.4
 High school diploma/GED 49 13.1 65.3
 Some college/technical/trade school 96 25.7 82.3
 Bachelor’s degree 110 29.5 88.2
 Graduate or professional school 80 21.5 95

Paternal education <0.001
 < High school graduate 39 10.4 56.4
 High school diploma/GED 67 18 67.2
 Some college/technical/trade school 92 24.7 84.8
 Bachelor’s degree 89 23.9 89.9
 Graduate or professional school 75 20.1 93.3
 Unknown 11 2.9 --b
a

arithmetic mean (standard deviation)

b

-- %BF for unknown category not included in chi-square test

Of the total sample, 302 (80.9%) women initiated breastfeeding, but only 42.4% breastfed as long as they had intended. The mean duration of any breastfeeding was 27.8 weeks (range 0.14–144; SD 22.68); the mean duration of exclusive breastfeeding was 3.9 weeks (range 0.14–28; SD 6.82). All socio-demographic indicators measured were associated with breastfeeding initiation (p<0.05), except mode of delivery, intrauterine growth and having a grandmother in the home. (Table 1)

Toxic Exposures and Breastfeeding

Cotinine, lead and the phthalate metabolite concentrations were not correlated (r<0.4). Each is addressed independently in the following paragraphs due to public health impact and precedent.

Serum cotinine

Based on self-report, 46 (12.3%) women reported smoking cigarettes at baseline; 92 (24.7%) were passively exposed to tobacco smoke. Prenatal serum cotinine concentration ranged from 0.001 to 355.5 μg/ml. On regression analysis, mothers who were unexposed to tobacco (cotinine <0.015μg/mL, n=126), any breastfeeding duration averaged 29.9 weeks compared with 24.9 weeks among women who were passively exposed (0.015–3.0μg/mL, n=194) (p=0.04). (Table 2 and Figure 2) The duration of any breastfeeding for women who were actively exposed (>3.0 μg/mL, n=25) was lower, at 22.4 weeks. Duration for active exposure was not significantly different than unexposed groups (p=0.12), but there was a significant linear trend for cotinine exposure and duration of any breastfeeding (p=0.03). Duration of exclusive breastfeeding was 2.7 weeks for women unexposed to tobacco, 2.1 weeks for women with passive exposure, and 3.2 weeks in women with active exposure (linear trend p=0.80).

Table 2.

Adjusted meana breastfeeding duration by categorical maternal prenatal toxin exposures

Any BF (wk) Exclusive BF (wk)
LSMeana (SE) p-valueb Linear trend p- value LSMeana(SE) p-valueb Linear trend p- value
Serum cotinine (μg/mL)c,e 0.03* 0.8
 Unexposed (<0.015) 29.9 (1.8) -- 2.7 (0.9) --
 Passive (0.015–3.0) 24.9 (1.6) 0.04* 2.1 (0.7) 0.51
 Active (>3.0) 22.4 (4.3) 0.12 3.2 (1.6) 0.81
Blood lead (μg/dL)d,e 0.38 0.69
 1st tercile (0.17–0.590) 27.1 (1.9) -- 2.3 (0.9) --
 2nd tercile (0.591–0.820) 24.2 (2.0) 0.3 2.4 (0.9) 0.85
 3rd tercile (0.821–3.45) 30.5 (2.3) 0.27 2.7 (0.9) 0.69
Urinary MECPP (μg/mL)d,e,f 0.11 0.97
 1st tercile (3.0–40.9) 28.4 (1.9) -- 2.9 (0.8) --
 2nd tercile (41.0–97.5) 28.0 (2.0) 0.89 1.5 (0.9) 0.13
 3rd tercile (97.6–1677.9) 23.9 (2.0) 0.11 3.0 (0.9) 0.94
Urinary MEHP (μg/mL) d,e,f 0.07 0.93
 1st tercile (0.85–5.34) 28.0 (1.9) -- 2.3 (0.9) --
 2nd tercile (5.35–15.8) 29.4 (1.9) 0.62 2.9 (0.8) 0.49
 3rd tercile (15.9–532.3) 22.9 (2.0) 0.07 2.3 (0.9) 0.95
Urinary MEOHP (μg/mL) d,e,f 0.09 0.98
 1st tercile (1.76–22.7) 29.3 (2.0) -- 2.7 (0.8) --
 2nd tercile (22.8–54.32) 26.6 (2.0) 0.32 2.0 (0.9) 0.46
 3rd tercile (54.33–704) 24.5 (2.0) 0.09 2.8 (0.9) 0.97

Maternal prenatal toxin exposure is average of 16w, 26w, and birth measures.

a

Adjusted means here are least squares means, controlling for identified covariates

b

p-value compared to lowest level of exposure

c

Any BF adjusted for maternal race and breastfeeding goal

d

Any BF adjusted for maternal race, breastfeeding goal, and maternal age

e

Exclusive BF adjusted for maternal race, biological father in the home, mode of delivery, breastfeeding goal.

f

Models further adjusted for maternal prenatal creatinine.

*

Statistically significant

Figure 2.

Figure 2

Breastfeeding duration and standard error by prenatal serum cotinine concentrations with linear trend significance reported

We observed similar associations for primiparous women. The average breastfeeding duration for the unexposed group was 30.5 weeks, compared with the passively exposed (23.8 weeks) and actively exposed groups (18.1 weeks, linear trend p=0.02). There were no significant differences in the duration of exclusive breastfeeding by cotinine exposure in the primiparous group.

We also examined whether women who were exposed to different cotinine levels reported meeting their breastfeeding goals. Sixty seven percent of women who were unexposed to tobacco stated they had breastfed as long as they wanted to, compared with 50% for those passively exposed and 52.6% of women who had active exposure (p=0.02).

Whole blood lead

Gestational whole blood lead levels ranged from 0.17 to 3.45 μg/dL. On regression analysis, the associated breastfeeding duration ranged from 24.2 – 30.5 weeks (linear trend p=0.38) and exclusive breastfeeding duration ranged from 2.4 – 2.7 weeks (linear trend p=0.69) (Table 2). In the primiparous sample, average breastfeeding duration for the lowest tercile of exposure was 24.3 weeks, and for the highest tercile was 31.6 (linear trend p=0.07). There were no significant differences in the primiparous group for duration of exclusive breastfeeding.

Urinary Phthalate Metabolites

Only 3 urinary phthalate metabolites, MECPP, MEHP and MEOHP, showed a significant relation to breastfeeding outcomes at the level of p<0.10. On regression analysis, we modeled breastfeeding duration for these 3 phthalate metabolites, comparing the middle (2nd) and highest (3rd) terciles with the lowest (1st) tercile (Table 2). Urinary levels ranged from 3.0 – 1677.9 μg/mL for MECPP, 0.85 – 532.3 μg/mL for MEHP, and 1.76 – 704.0 μg/mL for MEOHP. For MECPP, associated duration of any breastfeeding was 28.4 weeks for those women in the lowest tercile of exposure to MECPP and 23.9 weeks for the highest tercile of exposure to MECPP (linear trend p=0.11), while exclusive breastfeeding ranged from 1.5 – 3.0 weeks (linear trend p=0.97). For MEHP, women in the lowest tercile of exposure had a duration of any breastfeeding of 28 weeks, while those in the highest tercile breastfed 22.9 weeks (linear trend p=0.07). Exclusive breastfeeding for MEHP ranged from 2.3 to 2.9 weeks (linear trend p=0.93). For MEOHP, women in the lowest tercile of exposure breastfed for 29.3 weeks, while those in the highest tercile breastfed 24.5 weeks (linear trend p=0.09). Exclusive breastfeeding ranged from 2.0 to 2.8 weeks (linear trend p=0.98). None of the phthalates showed a significant association with any or exclusive breastfeeding duration in the primiparous sample.

Discussion

We found that passive gestational exposure to tobacco smoke was associated with breastfeeding duration, even after controlling for confounders. A strength of this study was in its prospective design, mitigating the impact of reverse causality and recall bias and thereby strengthening the possibility of a causal relationship between exposure and shortened breastfeeding duration. Women who had passive tobacco smoke exposure breastfed about 5 fewer weeks than those not exposed. Given the beneficial dose-response relationship of breastfeeding on infant and maternal health (Horta and Victora 2013; Ip et al. 2007), a reduction in breastfeeding by five weeks could adversely impact maternal and child health. Our primary result is reinforced by our parallel finding that more women in passively and actively exposed groups stated that they hadn’t breastfed as long as they had intended compared with unexposed women. Though it is possible that maternal return to work negatively affected duration, only 21% of women reported not meeting their goal because of back to work or school, whereas 49% reported not having enough milk or growth failure for their infants. This suggests that attainment of breastfeeding goals may be impacted by tobacco smoke exposure. Other investigators have concluded that the impact of active smoke exposure on breastfeeding duration might be related to parenting and breastfeeding choices rather than biologic mechanisms (Donath and Amir 2004; Logan et al. 2016). In contrast, our findings and other studies indicate that a biological mechanism may be involved (Vio et al. 1991; Jedrychowski 2008a). Our data do not address the nature of this mechanism, but Lawrence and Lawrence have suggested that passive smoke exposure may have a toxic impact on the ongoing development of the mammary gland during pregnancy, or disrupt hormonal signaling (Lawrence and Lawrence 2015). These hypothesized effects would presumably reduce the mother’s milk supply, thus making the breastfeeding experience less adequate for infant nutrition. Though few animal studies have investigated the effect of cigarette exposure on lactation, one study may support this biological claim in which rat offspring had slower growth after maternal exposure to cigarette smoke during pregnancy and lactation (Gaworski et al. 2004).

If a biological mechanism is at play, one might expect that duration of exclusive breastfeeding would be similarly abbreviated, and that women with cotinine exposures >3.0 μg/mL (i.e., active smokers) would also show significantly shortened breastfeeding durations. We did not see this in our study, though there was a significant trend toward further declines in duration and only 12% of women were active smokers. Of note, exclusive breastfeeding rates in our sample were much lower than National and Ohio state figures from the same time period, and thus are not representative of a statewide or national cohort (CDC 2003; CDC 2004). It is possible that an association between passive tobacco smoke exposure and exclusive breastfeeding would be observed in a larger, more representative sample. Alternatively, it is possible that women who were especially motivated to breastfeed, as indicated by the choice to exclusively breastfeed, were able to overcome the potential diminished production of breastmilk linked to tobacco exposure.

Lead exposure was not associated with shortened breastfeeding duration. Indeed, primiparous women in the highest tercile of exposure breastfed longer in our sample, though this finding wasn’t significant. Similarly, we found no association between levels of urinary phthalate metabolite excretion and shortened breastfeeding duration. We saw marginally significant associations for MEHP and MEOHP which deserves further investigation. Though most animal studies on phthalates have focused on lactation as a means of exposure, one study in rats found lower weight gain in offspring during lactation after parental exposure to di-isononyl phthalate (Waterman et al 2000). Another study found decreased milk production, mammary gland weight and offspring growth after dam exposure to di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate (MEHP) (Dostal et al 1987). In addition, it is possible that the clinical effect of phthalates may be additive, particularly within high molecular weight and low molecular weight groups, which deserves further consideration (Kay, et al. 2013).

Breastfeeding is both the physiologically normal infant feeding method and promotes optimal infant and maternal health (Eidelman and Schanler 2012). Many women face barriers to reaching their breastfeeding goals, and the role of ubiquitous environmental toxins in this process deserves additional attention. Our analysis of the potential impact of these ubiquitous toxins on breastfeeding may therefore help us to improve the experiences of breastfeeding women. Further research is needed to clarify these associations and expand our understanding of the potential impact these, and other, toxins may have on breastfeeding experiences.

This study had several limitations. First, our sample may not be representative. Mothers in the HOME Study had lower rates of exclusive breastfeeding and briefer breastfeeding duration than women in Ohio and national samples during this time period (CDC 2003; CDC 2004), and high educational levels. They also had lower rates of smoking. Given that socio-cultural factors related to breastfeeding may also be associated with the extent of exposures to environmental chemicals, this suggests that our positive results may represent potential unmeasured confounding. Using significance tests to identify confounders allowed us to find associations but not etiologies. Also, we did not examine the impact of postnatal exposures to toxins on breastfeeding duration, or use data on when women returned to work, as breastfeeding durations were short. Though provision of mother’s milk by expression or direct breastfeeding were treated equally, sociodemographics between these two groups may have differed, thus creating unforeseen confounding. Finally, given the stability of exposure over the three time periods, and our resultant use of an average level of toxin exposure through pregnancy, we were unable to determine if there are more sensitive periods in gestation associated with decreased breastfeeding duration.

Conclusions for Practice

Maternal prenatal serum cotinine, at levels consistent with passive tobacco smoke exposure, were associated with shortened duration of any breastfeeding and marginally associated with cigarette smoking. Our findings add to prior research showing decreased breastfeeding duration in mothers who were exposed to tobacco during pregnancy, and provide further reason for pregnant women to avoid passive and active exposure. If indeed such causal relationships exist, then breastfeeding counseling should include discussion of potential impacts of passive exposure. Additionally, if further research elaborates a link between phthalates and breastfeeding duration, impact on manufacturing policy and population exposures could be extensive.

Significance.

What is already known on the subject?

Maternal exposure to tobacco smoke has been associated with shortened breastfeeding duration, though less is known about prenatal exposure. Few studies have examined the effects on breastfeeding outcomes of low level exposures to other toxic chemicals.

What this study adds?

This study showed that low-level passive exposure to tobacco smoke in the prenatal period has potentially deleterious effects on breastfeeding duration. However, this was not seen with phthalates and lead.

Acknowledgments

This work was supported by grants from the National Institute of Environmental Health Sciences (NIEHS; P01 ES11261, R01 ES014575). We acknowledge the technical assistance of the Centers for Disease Control and Prevention for laboratory measurements: AM Calafat (phthalate metabolites), R Jones and KC Caldwell (lead), and JT Bernert (cotinine).

Footnotes

Declarations:

Dr. Lanphear has served as an expert witness and a consultant to the California Attorney General’s Office for the plaintiffs in a public nuisance case related to childhood lead poisoning, but he has not personally received any compensation for these services. Dr. Lanphear has also served as a paid consultant on a US Environmental Protection Agency research study related to childhood lead poisoning. None of these activities are directly related to the present study.

Contributor Information

Casey B Rosen-Carole, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Peggy Auinger, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Cynthia R Howard, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Elizabeth A Brownell, Connecticut Children’s Medical Center, Hartford, CT, USA.

Bruce P Lanphear, Simon Fraser University, Vancouver, British Columbia, Canada.

References

  • 1.Amir LH, Donath SM. Does maternal smoking have a negative physiological effect on breastfeeding? The epidemiological evidence. Birth. 2002;29(2):112–23. doi: 10.1046/j.1523-536x.2002.00152.x. [DOI] [PubMed] [Google Scholar]
  • 2.Barbosa F, Tanus-Santos JE, Gerlach F, Parsons PJ. A Critical Review of Biomarkers Used for Monitoring Human Exposure to Lead: Advantages, Limitations, and Future Needs Environ Health Perspect. 2005;113(12): 1669–1674. doi: 10.1289/ehp.7917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113(2):192–200. doi: 10.1289/ehp.7337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boas M, Feldt-Rasmussen U, Main KM. Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol. 2012;355(2):240–8. doi: 10.1016/j.mce.2011.09.005. [DOI] [PubMed] [Google Scholar]
  • 5.Braun JM, Daniels JL, Poole C, Olshan AF, Hornung R, Bernert JT, Xia Y, Bearer C, Barr DB, Lanphear BP. A prospective cohort study of biomarkers of prenatal tobacco smoke exposure: the correlation between serum and meconium and their association with infant birth weight. Environ Health. 2010;9:53. doi: 10.1186/1476-069X-9-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Braun JM, Sathyanarayana S, Hauser R. Phthalate Exposure and Children’s Health. Curr Opin Pediatr. 2013;25(2): 247–254. doi: 10.1097/MOP.0b013e32835e1eb6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition, Physical Activity and Obesity. Nutrition, Physical Activity and Obesity Data, Trends and Maps web site. U.S. Department of Health and Human Services; Atlanta, GA: 2015. Available at http://www.cdc.gov/nccdphp/DNPAO/index.html. [Google Scholar]
  • 8.Centers for Disease Control and Prevention (CDC), Emergency Response and Air Toxicants Branch, Division of Laboratory Sciences, National Center for Environmental Health. Laboratory Procedure Manual: Cotinine, Serum, Method:HPLC - APCI Tandem Mass Spectrometry, Method No:2000.02. 2008 Available at: https://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/cot_e_met.pdf.
  • 9.Cernadas JM, Noceda G, Barrera L, Martinez AM, Garsd A. Maternal and perinatal factors influencing the duration of exclusive breastfeeding during the first 6 months of life. J Hum Lact. 2003;19:136–44. doi: 10.1177/0890334403253292. [DOI] [PubMed] [Google Scholar]
  • 10.Chou SY, Hsu HH, Kuo HH, Kuo HW. Association between exposure to environmental tobacco smoke (ETS) and breastfeeding behaviour. Acta Paediatr. 2008;97(1):76–80. doi: 10.1111/j.1651-2227.2007.00593.x. [DOI] [PubMed] [Google Scholar]
  • 11.Dagher RK, McGovern PM, Schold JD, Randall XJ. Determinants of breastfeeding initiation and cessation among employed mothers: a prospective cohort study. BMC Pregnancy Childbirth. 2016;16(1):194. doi: 10.1186/s12884-016-0965-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Donath SM, Amir LH ALSPAC Study Team. The relationship between maternal smoking and breastfeeding duration after adjustment for maternal infant feeding intention. Acta Paediatr. 2004;93(11):1514–1518. doi: 10.1080/08035250410022125. [DOI] [PubMed] [Google Scholar]
  • 13.Dostal LA, Weaver RP, Schwetz BA. Transfer of di(2-ethylhexyl) phthalate through rat milk and effects on milk composition and the mammary gland. Toxicol Appl Pharmacol. 1987;91(3):315–25. doi: 10.1016/0041-008x(87)90054-8. [DOI] [PubMed] [Google Scholar]
  • 14.Dzwilewski KL, Schantz SL. Prenatal chemical exposures and child language development. J Commun Disord. 2015;57:41–65. doi: 10.1016/j.jcomdis.2015.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Eidelman A, Schanler R. American Academy of Pediatrics Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics. 2012;129(3):e827–841. [Google Scholar]
  • 16.Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit. 2006;12(3):RA57–65. [PubMed] [Google Scholar]
  • 17.Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Rev. 2015;36(6):E1–E150. doi: 10.1210/er.2015-1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Green BB, Marsit CJ. Select Prenatal Environmental Exposures and Subsequent Alterations of Gene-Specific and Repetitive Element DNA Methylation in Fetal Tissues. Curr Environ Health Rep. 2015;2(2):126–36. doi: 10.1007/s40572-015-0045-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hauser R, Gaskins AJ, Souter I, Smith KW, Dodge LE, Ehrlich S, Meeker JD, Calafat AM, Williams PL EARTH Study Team. Urinary Phthalate Metabolite Concentrations and Reproductive Outcomes among Women Undergoing in Vitro Fertilization: Results from the EARTH Study. Environ Health Perspect. 2015;124(6):831–9. doi: 10.1289/ehp.1509760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Horta B, Victora C. Long-term effects of breastfeeding: A systematic review. Geneva, Switzerland: World Health Organization; 2013. [Google Scholar]
  • 21.Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, Trikalinos T, Lau J. Breastfeeding and maternal and infant health outcomes in developed countries. Evidence Report/Technology Assessment. 2007;153:1–186. [PMC free article] [PubMed] [Google Scholar]
  • 22.Jedrychowski W, Perera F, Mroz E, Edwards S, Flak E, Rauh V, Pac A, Budzyn-Mrozek D, Musiał A. Prenatal exposure to passive smoking and duration of breastfeeding in nonsmoking women: Krakow inner city prospective cohort study. Arch Gynecol Obstet. 2008a;278(5):411–7. doi: 10.1007/s00404-008-0607-6. [DOI] [PubMed] [Google Scholar]
  • 23.Jedrychowski W1, Perera F, Jankowski J, Rauh V, Flak E, Caldwell KL, Jones RL, Pac A, Lisowska-Miszczyk I. Prenatal low-level lead exposure and developmental delay of infants at age 6 months (Krakow inner city study) Int J Hyg Environ Health. 2008b;211(3–4):345–51. doi: 10.1016/j.ijheh.2007.07.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Johns LE, Cooper GS, Galizia A, Meeker JD. Exposure assessment issues in epidemiology studies of phthalates. Environ Int. 2015a;85:27–39. doi: 10.1016/j.envint.2015.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Johns LE, Ferguson KK, Soldin OP, Cantonwine DE, Rivera-González LO, Del Toro LV, Calafat AM, Ye X, Alshawabkeh AN, Cordero JF, Meeker JD. Urinary phthalate metabolites in relation to maternal serum thyroid and sex hormone levels during pregnancy: a longitudinal analysis. Reprod Biol Endocrinol. 2015b;13:4. doi: 10.1186/1477-7827-13-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, Brown MJ. Pediatrics. Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988–2004. Pediatrics. 2009;123(3):e376–85. doi: 10.1542/peds.2007-3608. [DOI] [PubMed] [Google Scholar]
  • 27.Jurewicz J, Polańska K, Hanke W. Chemical exposure early in life and the neurodevelopment of children--an overview of current epidemiological evidence. Ann Agric Environ Med. 2013;20(3):465–86. [PubMed] [Google Scholar]
  • 28.Kay VR, Chambers C, Foster WG. Reproductive and developmental effects of phthalate diesters in females. Crit Rev Toxicol. 2013;43(3):200–19. doi: 10.3109/10408444.2013.766149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kehler HL, Chaput KH, Tough SC. Risk factors for cessation of breastfeeding prior to six months postpartum among a community sample of women in Calgary, Alberta. Can J Public Health. 2009;100(5):376–80. doi: 10.1007/BF03405274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim S, Lee J, Park J, Kim HJ, Cho G, Kim GH, Eun SH, Lee JJ, Choi G, Suh E, Choi S, Kim S, Kim YD, Kim SK, Kim SY, Kim S, Eom S, Moon HB, Kim S, Choi K. Concentrations of phthalate metabolites in breast milk in Korea: estimating exposure to phthalates and potential risks among breast-fed infants. Sci Total Environ. 2015;508:13–9. doi: 10.1016/j.scitotenv.2014.11.019. [DOI] [PubMed] [Google Scholar]
  • 31.LaKind JS, Amina Wilkins A, Berlin CM., Jr Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research. Toxicol Appl Pharmacol. 2004;198(2):184–208. doi: 10.1016/j.taap.2003.08.021. [DOI] [PubMed] [Google Scholar]
  • 32.LaKind JS, Berlin CM, Mattison DR. The heart of the matter on breastmilk and environmental chemicals: essential points for healthcare providers and new parents. Breastfeed Med. 2008;3:251–9. doi: 10.1089/bfm.2008.0121. [DOI] [PubMed] [Google Scholar]
  • 33.LaKind JS, Fenton SE, Dórea JG. Human milk biomonitoring of phthalates: Expanding our understanding of infant exposure is compatible with supporting breastfeeding. J Agric Food Chem. 2015;63(12):3303–10. doi: 10.1016/j.envint.2009.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lambers DS, Clark KE. The Maternal and Fetal Physiologic Effects of Nicotine. Seminars in Perinatology. 1996;20(2):115–126. doi: 10.1016/s0146-0005(96)80079-6. [DOI] [PubMed] [Google Scholar]
  • 35.Leung GM, Ho LM, Lam TH. Maternal, paternal and environmental tobacco smoking and breast feeding. Paediatr Perinat Epidemiol. 2002;16(3):236–45. doi: 10.1046/j.1365-3016.2002.00426.x. [DOI] [PubMed] [Google Scholar]
  • 36.Lawrence RA, Lawrence RM. Breastfeeding A Guide for the Medical Profession. 8. Elsevier; GA: 2015. [Google Scholar]
  • 37.Liu J, Rosenberg KD, Sandoval AP. Breastfeeding duration and perinatal cigarette smoking in a population-based cohort. Am J Public Health. 2006;96(2):309–14. doi: 10.2105/AJPH.2004.060798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Logan C, Zittel T, Striebel S, Reister F, Brenner H, Rothenbacher D, Genunei J. Changing Societal and Lifestyle Factors and Breastfeeding Patterns Over Time. 2016;137(5) doi: 10.1542/peds.2015-4473. Epub ahead of print April 2016. [DOI] [PubMed] [Google Scholar]
  • 39.McLeod D, Pullon S, Cookson T. Factors influencing continuation of breastfeeding in a cohort of women. J Hum Lact. 2002;18:335–43. doi: 10.1177/089033402237906. [DOI] [PubMed] [Google Scholar]
  • 40.Nixon DE, Burritt MF, Moyer TP. The determination of mercury in whole blood and urine by inductively coupled plasma mass spectrometry. Spectrochim Acta Part B At Spectrosc. 1999;54(8):1141–1153. [Google Scholar]
  • 41.Romano ME, Yingying Xu, Calafat AM, Yolton K, Chen A, Webster GM, Eliot MN, Howard CR, Lanphear BP, Braun JM. Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding. Environmental Research. 2016;149:239–246. doi: 10.1016/j.envres.2016.04.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Shah-Kulkarni S, Ha M, Kim E, Hong YC, Park H, Kim Y, Kim BN, Chang N, Oh SY, Kim’s YJ, Lee B, Ha EH. Neurodevelopment in Early Childhood Affected by Prenatal Lead Exposure and Iron Intake. Medicine. 2016;95(4):e2508. doi: 10.1097/MD.0000000000002508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Silva MJ, Samandar E, Preau JL, Jr, Reidy JA, Needham LL, Calafat AM. Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;860(1):106–12. doi: 10.1016/j.jchromb.2007.10.023. [DOI] [PubMed] [Google Scholar]
  • 44.Sriraman NK, Kellams A. Breastfeeding: What are the Barriers? Why Women Struggle to Achieve Their Goals. J Womens Health (Larchmt) 2016;25(7):714–22. doi: 10.1089/jwh.2014.5059. [DOI] [PubMed] [Google Scholar]
  • 45.Vio F, Salazar G, Infante C. Smoking during pregnancy and lactation and its effects on breast-milk volume. Am J Clin Nutr. 1991;54(6):1011–1016. doi: 10.1093/ajcn/54.6.1011. [DOI] [PubMed] [Google Scholar]
  • 46.Waterman SJ, Keller LH, Trimmer GW, Freeman JJ, Nikiforov AI, Harris SB, Nicolich MJ, McKee RH. Two-generation reproduction study in rats given di-isononyl phthalate in the diet. Reprod Toxicol. 2000;14(1):21–36. doi: 10.1016/s0890-6238(99)00067-2. [DOI] [PubMed] [Google Scholar]
  • 47.Weiser TM, Lin M, Garikapaty V, Feyerharm RW, Bensyl DM, Zhu BP. Association of maternal smoking status with breastfeeding practices: Missouri, 2005. Pediatrics. 2009;124(6):1603–10. doi: 10.1542/peds.2008-2711. [DOI] [PubMed] [Google Scholar]
  • 48.Werner EF, Braun JM, Yolton K, Khoury JC, Lanphear BP. The association between maternal urinary phthalate concentrations and blood pressure in pregnancy: The HOME Study. Environ Health. 2015;14:75. doi: 10.1186/s12940-015-0062-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ye L, Guo J, Ge RS. Environmental pollutants and hydroxysteroid dehydrogenases. Vitam Horm. 2014;94:349–90. doi: 10.1016/B978-0-12-800095-3.00013-4. [DOI] [PubMed] [Google Scholar]

RESOURCES